The revised EU pharmaceutical policy maintains eight-year data protection but reduces market protection to one year, ...

Discover how drugs prevent, cure, and alleviate ailments. Learn about over-the-counter vs. prescription drugs and the ...

A push to reshore some drug production and progress in advanced manufacturing technologies have been prominent trends this year, industry leaders say.

Low compliance by the country’s 8,500 small and medium enterprises (MSMEs) manufacturing pharmaceuticals would raise the risk ...

Ipsen gains exclusive global rights, outside of Greater China, for development, manufacturing and commercialization of SIM0613, a ...

It’s no secret. Drug development and clinical research continue to get more complex. And with that increasing complexity come ...

Geneticist Michael Klotsman was frustrated by human drug development. That led him to launch a startup focused on treatments ...

Representatives of companies including AbbVie, Eli Lilly, Johnson & Johnson and Merck have voiced concerns about the FDA’s ...

The EU is set to introduce new incentives to stimulate pharmaceutical R&D, particularly for new antibiotics and treatments for rare diseases, after lawmakers reached a provisional agreement on ...

China Medical System Holdings Limited ('CMS”, or the 'Group”) is pleased to announce that its subsidiary, Dermavon Holdings Limited ('Dermavon”, an innovative pharmaceutical company specialized in ...

The year 2025 was defined by escalating global trade tensions that fundamentally reshaped the pharmaceutical supply chain, ...

Amphastar Pharmaceuticals faces flat growth and margin pressure as it shifts from generics to branded drugs. Learn why AMPH ...